Dublin, Aug. 14, 2019 (GLOBE NEWSWIRE) -- The "2020 Global Drug Bioavailability Enhancement Summit" conference has been added to ResearchAndMarkets.com's offering.
It's no lie the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the need for novel adherence strategies, pharma and biotech, now more than ever need to initiate innovative formulation, delivery and development approaches in order to improve bioavailability and therapeutic performance.
The 2020 Global Drug Bioavailability Enhancement Summit will connect industry leaders from both mall molecule and biologics areas to address challenges at the interface between drug discovery and preclinical/clinical development. 2020's Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities. Hear from 30+ senior drug bioavailability pioneers and network with 120+ senior drug development innovators and walk away wit over 2 years of new drug formulation and bioavailability enhancement approaches strategies in just 2 days!
Are you looking to improve drug performance, bioavailability and patient adherence? Would you like to reduce dosage, cost and time-to-market? Get involved today at the 2020 Summit and dramatically increase the performance and activity of your current and future drug products.
You Will Learn
Benefits
Who Should Attend?
Pharmaceutical, biotech and academic professionals specializing in:
For more information about this conference visit https://www.researchandmarkets.com/r/61hhpc
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900